市場調査レポート

商品コード

1158552

感染症検査向け分子診断の世界市場：北米が引き続き世界市場の成長を牽引

Market Study on Molecular Diagnostics in Infectious Disease Testing: North America to Continue Leading Global Market Growth

出版日: 2022年09月28日 | 発行: Persistence Market Research

| ページ情報: 英文 250 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピーはできません。PDFの印刷もできません。

PDF (Multi User License)

USD 7,600 1,191,376円

レポートPDFを同一企業内の5名様までご利用頂けるライセンスです。PDF内のテキストの編集が可能です。PDFの印刷は5部までとし、そのご利用はPDFのご利用範囲に準拠します。

PDF (Corporate User License)

USD 10,600 1,661,656円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキストの編集が可能です。印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートでは、世界の感染症検査向け分子診断市場について調査分析し、2022年～2032年の予測期間における、市場概要、動向、セグメント別・地域別の市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

マクロ経済要因
- GDP成長見通し
- 個人消費見通し
- GDP成長率分析
- 所得層人口の概要
- 一人当たり可処分所得
予測要因：関連性と影響
- 主要企業の成長履歴
- 都市化の成長見通し
- その他
世界の感染症検査向け分子診断市場のPESTLE分析
感染症検査向け分子診断市場の投資実現可能性マトリクス
世界の感染症検査向け分子診断市場におけるポーターのファイブフォース分析
市場力学
- 促進要因
- 抑制要因
- 機会分析

第9章世界の感染症検査向け分子診断市場分析と予測：製品別

イントロダクション/主要な調査結果
過去の市場分析：製品別
現在・将来の市場分析と予測：製品別
- 計測器と分析器
- アッセイと試薬
- サービスとソフトウェア
市場の魅力分析：製品別

第10章世界の感染症検査向け分子診断市場分析と予測：用途別

イントロダクション/主要な調査結果
過去の市場分析：用途別
現在・将来の市場分析と予測：用途別
- B型肝炎
- C型肝炎
- AIDS
- 結核
- メチシリン耐性黄色ブドウ球菌（MRSA）
- 院内感染
- クラミジア・トラコマチスと淋菌（CT/NG）
- ヒトパピローマウイルス（HPV）感染症
- その他
市場の魅力分析：用途別

第11章世界の感染症検査向け分子診断市場分析と予測：技術別

イントロダクション/主要な調査結果
ヒストリカルマーケットと分析：技術別
現在・将来の市場分析と予測：技術別
- ポリメラーゼ連鎖反応（PCR）
- 等温核酸増幅技術（INAAT）
- マイクロアレイ
- 次世代シーケンシング（NGS）
- ハイブリダイゼーション
- その他
市場の魅力分析：技術別

第12章世界の感染症検査向け分子診断市場分析と予測：エンドユーザー別

イントロダクション/主要な調査結果
過去の市場分析：エンドユーザー別
現在・将来の市場分析と予測：エンドユーザー別
- 病院
- プライベートラボ
- クリニック
- 学術機関
- 研究所
- その他
市場の魅力分析：エンドユーザー別

第13章世界の感染症検査向け分子診断市場分析と予測：地域別

イントロダクション
過去の市場分析：地域別
現在の市場分析と予測：地域別
- 北米
- ラテンアメリカ
- 欧州
- 東アジア
- 南アジア
- オセアニア
- 中東・アフリカ（MEA）
市場の魅力分析：地域別

第14章北米の感染症検査向け分子診断市場分析と予測

イントロダクション
価格分析
過去の市場・数量動向分析：市場分類別
市場・数量予測：市場分類別
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別
市場の魅力分析
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別

第15章ラテンアメリカの感染症検査向け分子診断市場分析と予測

イントロダクション
価格分析
過去の市場・数量動向分析：市場分類別
市場・数量予測：市場分類別
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別
市場の魅力分析
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別

第16章欧州の感染症検査向け分子診断市場分析と予測

イントロダクション
価格分析
過去の市場・数量動向分析：市場分類別
市場・数量予測：市場分類別
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別
市場の魅力分析
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別

第17章南アジアの感染症検査向け分子診断市場分析と予測

イントロダクション
価格分析
過去の市場・数量動向分析：市場分類別
市場・数量予測：市場分類別
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別
市場の魅力分析
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別

第18章東アジアの感染症検査向け分子診断市場分析と予測

イントロダクション
価格分析
過去の市場・数量動向分析：市場分類別
市場・数量予測：市場分類別
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別
市場の魅力分析
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別

第19章オセアニアの感染症検査向け分子診断市場分析と予測

イントロダクション
価格分析
過去の市場・数量動向分析：市場分類別
市場・数量予測：市場分類別
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別
市場の魅力分析
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別

第20章中東・アフリカの感染症検査向け分子診断市場分析と予測

イントロダクション
価格分析
過去の市場・数量動向分析：市場分類別
市場・数量予測：市場分類別
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別
市場の魅力分析
- 国別
- 製品別
- エンドユーザー別
- 用途別
- 技術別

第21章主要国の感染症検査向け分子診断市場分析

イントロダクション
- 市場価値比率分析：主要国別
- 世界と国の成長比較
米国
カナダ
メキシコ
ブラジル
ドイツ
イタリア
英国
中国
日本
韓国
インド
オーストラリア・ニュージーランド
南アフリカ

第22章市場構造分析

市場分析：企業層別（感染症検査向け分子診断）
市場集中度
主要企業の市場シェア分析
市場プレゼンス分析
- 企業の地域フットプリント別
- 製品フットプリント：企業別
- チャネルフットプリント：企業別

第23章競合分析

競合ダッシュボード
価格分析：競合別
競合ベンチマーク
競合の詳細
- Abbott Laboratories
- Becton
- Dickinson and Company
- bioMerieux
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Siemens AG
- Veridex, LLC
- Luminex Corp.
- GenMark Diagnostics, Inc.
- Qiagen N.V.
- Genomix Biotech
- bioTheranostics

第24章前提条件と使用されている頭字語

第25章調査手法

図表

List of Tables

Table 1: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 2: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 3: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 4: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 5: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 6: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 7: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 8: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
Table 9: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Region, 2017-2032
Table 10: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Region, 2017-2032
Table 11: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
Table 12: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
Table 13: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 14: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 15: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 16: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 17: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 18: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 19: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 20: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
Table 21: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
Table 22: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
Table 23: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 24: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 25: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 26: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 27: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 28: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 29: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 30: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
Table 31: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
Table 32: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
Table 33: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 34: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 35: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 36: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 37: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 38: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 39: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 40: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
Table 41: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
Table 42: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
Table 43: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 44: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 45: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 46: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 47: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 48: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 49: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 50: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
Table 51: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
Table 52: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
Table 53: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 54: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 55: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 56: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 57: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 58: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 59: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 60: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
Table 61: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
Table 62: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
Table 63: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 64: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 65: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 66: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 67: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 68: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 69: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 70: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
Table 71: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
Table 72: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
Table 73: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
Table 74: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
Table 75: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
Table 76: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
Table 77: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
Table 78: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
Table 79: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
Table 80: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032

List of Figures

Figure 01: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume ('000 Units) Analysis, 2017-2021
Figure 02: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume ('000 Units) Forecast 2022-2032
Figure 03: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis, 2017-2021
Figure 04: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Forecast, 2022-2032
Figure 05: Global Molecular Diagnostics in Infectious Disease Testing Absolute $ Opportunity (US$ Mn) 2022-2032
Figure 06: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 07: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 08: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 09: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 10: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 11: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 12: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 13: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 14: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
Figure 15: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
Figure 16: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
Figure 17: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
Figure 18: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 19: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 20: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 21: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 22: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Region, 2017-2032
Figure 23: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Region, 2017-2032
Figure 24: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Region, 2022-2032
Figure 25: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Region, 2022-2032
Figure 26: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 27: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
Figure 28: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
Figure 29: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
Figure 30: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 31: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 32: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 33: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 34: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 35: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 36: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 37: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 38: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
Figure 39: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
Figure 40: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
Figure 41: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
Figure 42: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 43: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 44: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 45: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 46: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 47: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
Figure 48: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
Figure 49: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
Figure 50: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 51: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 52: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 53: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 54: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 55: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 56: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 57: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 58: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 59: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 60: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 61: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 62: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 63: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 64: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 65: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 66: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 67: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
Figure 68: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
Figure 69: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
Figure 70: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 71: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 72: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 73: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 74: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 75: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 76: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 77: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 78: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
Figure 79: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
Figure 80: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
Figure 81: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
Figure 82: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 83: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 84: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 85: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 86: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 87: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
Figure 88: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
Figure 89: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
Figure 90: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 91: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 92: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 93: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 94: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 95: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 96: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 97: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 98: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
Figure 99: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
Figure 100: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
Figure 101: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
Figure 102: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 103: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 104: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 105: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 106: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 107: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
Figure 108: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
Figure 109: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
Figure 110: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 111: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 112: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 113: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 114: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 115: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 116: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 117: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 118: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
Figure 119: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
Figure 120: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
Figure 121: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
Figure 122: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 123: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 124: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 125: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 126: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 127: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
Figure 128: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
Figure 129: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
Figure 130: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 131: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 132: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 133: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 134: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 135: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 136: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 137: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 138: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
Figure 139: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
Figure 140: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
Figure 141: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
Figure 142: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 143: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 144: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 145: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
Figure 146: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
Figure 147: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
Figure 148: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
Figure 149: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
Figure 150: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
Figure 151: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
Figure 152: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
Figure 153: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
Figure 154: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
Figure 155: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
Figure 156: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
Figure 157: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
Figure 158: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
Figure 159: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
Figure 160: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
Figure 161: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
Figure 162: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 163: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
Figure 164: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
Figure 165: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032

Product Code: PMRREP4427

Report Scope:

Persistence Market Research recently published a new report on the molecular diagnostics in infectious disease testing market for the assessment period of 2022-2032. The report offers a close look at the evolving aspects of the market, and insights into the dynamics impacting market growth. It also focuses on key developments in the market, especially due to the COVID-19 pandemic situation that has affected people, globally. The report includes various macro- and micro-economic factors responsible for a significant impact on market growth.

The report on the molecular diagnostics in infectious disease testing market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis underlines untapped corners for aspiring players. The report also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.

All stakeholders in the molecular diagnostics in infectious disease testing market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in this space.

The report elaborates on both, historical and current trends shaping the molecular diagnostics in infectious disease testing market. The performance journey of the market has been drawn and analyzed to make the lucrative opportunities in the market evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies manufacturing molecular diagnostics in infectious disease testing, along with their differential strategies and key focus areas.

Segmentation

The research study offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The market is segmented on the basis of product, application, technique, end user, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.

Product

Instruments and Analyzers
Assays and Reagents
Services and Software

Application

Hepatitis B
Hepatitis C
AIDS
Tuberculosis
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Hospital-Acquired Infections
Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
Human Papillomavirus (HPV) Infection
Others

Technique

Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others

End User

Hospitals
Private Labs
Clinics
Academic Institutes
Laboratories
Others

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Abbott Laboratories, Becton, Dickinson and Company, bioMerieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.

Key Questions Answered in Report

The research study on the manufacturing molecular diagnostics in infectious disease testing market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

Will the polymerase chain reaction (PCR) segment continue driving the sales of molecular diagnostics in infectious disease testing market?

How are technological developments aiding molecular diagnostics in infectious disease testing market?

Which region is a key contributor to the global molecular diagnostics in infectious disease testing market?

Research Methodology

A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.

The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.

1. Executive Summary

1.1. Global Market Overview
1.2. Summary of Key Statistics
1.3. Summary of Key Findings
1.4. Product Evolution Analysis
1.5. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Future Prospects of Molecular Diagnostics in Infectious Disease Testing Industry
- 3.2.1. Factors Fuelling Growth
- 3.2.2. Influx of Brands
- 3.2.3. Innovative Distribution & Marketing Strategies

4. Rules and Regulations

4.1. Warning Labels
4.2. Regulatory Options for Little Cigars
- 4.2.1. Product Description
- 4.2.2. Health Risks
- 4.2.3. End Usering
- 4.2.4. Minimum Pack Technique Regulatory Gap
4.3. Cigar Labeling and Warning Statement Requirements by FDA
4.4. Tobacco Control Laws
- 4.4.1. Use of E-Cigarettes is Prohibited
- 4.4.2. Tobacco Advertising is Prohibited in Mass Media
- 4.4.3. Others
4.5. Others (During the Course of Study)

5. Global Molecular Diagnostics in Infectious Disease Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

5.1. Historical Market Volume ('000 Units) Analysis, 2017-2021
5.2. Current and Future Market Volume ('000 Units) Projections, 2022-2032
5.3. Y-o-Y Growth Trend Analysis

6. Global Molecular Diagnostics in Infectious Disease Testing Market - Pricing Analysis

6.1. Pricing Analysis By Product
6.2. Global Average Pricing Analysis Benchmark

7. Global Molecular Diagnostics in Infectious Disease Testing Market Demand (in Value or Technique in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

8.1. Global Cigar industry Outlook
- 8.1.1. Perception of Cigars
- 8.1.2. Prevalence of Smoking Cigars among Adults
- 8.1.3. Top 10 Cigars & Cigarillo Companies in the World
8.2. Macro-Economic Factors
- 8.2.1. GDP Growth Outlook
- 8.2.2. Consumer Spending Outlook
- 8.2.3. GDP Growth Rate Analysis
- 8.2.4. Income Group Population Overview
- 8.2.5. Per Capita Disposable Income
8.3. Forecast Factors - Relevance & Impact
- 8.3.1. Top Companies Historical Growth
- 8.3.2. Urbanization Growth Outlook
- 8.3.3. Others
8.4. PESTLE Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
8.5. Investment Feasibility Matrix of Molecular Diagnostics in Infectious Disease Testing Market
8.6. Porter's Five Forces Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
8.7. Market Dynamics
- 8.7.1. Drivers
- 8.7.2. Restraints
- 8.7.3. Opportunity Analysis

9. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Product, 2017 - 2021
9.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Product, 2022 - 2032
- 9.3.1. Instruments and Analyzers
- 9.3.2. Assays and Reagents
- 9.3.3. Services and Software
9.4. Market Attractiveness Analysis by Product

10. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Application, 2017 - 2021
10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Application, 2022 - 2032
- 10.3.1. Hepatitis B
- 10.3.2. Hepatitis C
- 10.3.3. AIDS
- 10.3.4. Tuberculosis
- 10.3.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
- 10.3.6. Hospital-Acquired Infections
- 10.3.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
- 10.3.8. Human Papillomavirus (HPV) Infection
- 10.3.9. Others
10.4. Market Attractiveness Analysis by Application

11. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technique

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Technique, 2017 - 2021
11.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Technique, 2022 - 2032
- 11.3.1. Polymerase Chain Reaction (PCR)
- 11.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
- 11.3.3. Microarrays
- 11.3.4. Next-Generation Sequencing (NGS)
- 11.3.5. Hybridization
- 11.3.6. Others
11.4. Market Attractiveness Analysis by Technique

12. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Flavor, 2017 - 2021
12.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Flavor, 2022 - 2032
- 12.3.1. Hospitals
- 12.3.2. Private Labs
- 12.3.3. Clinics
- 12.3.4. Academic Institutes
- 12.3.5. Laboratories
- 12.3.6. Others
12.4. Market Attractiveness Analysis by Flavor

13. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region

13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Region, 2017 - 2021
13.3. Current Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Region, 2022 - 2032
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. East Asia
- 13.3.5. South Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis by Region

14. North America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
- 14.4.1. By Country
  - 14.4.1.1. U.S.
  - 14.4.1.2. Canada
- 14.4.2. By Product
- 14.4.3. By End User
- 14.4.4. By Application
- 14.4.5. By Technique
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Product
- 14.5.3. By End User
- 14.5.4. By Application
- 14.5.5. By Technique

15. Latin America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
- 15.4.1. By Country
  - 15.4.1.1. Brazil
  - 15.4.1.2. Mexico
  - 15.4.1.3. Rest of Latin America
- 15.4.2. By Product
- 15.4.3. By End User
- 15.4.4. By Application
- 15.4.5. By Technique
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Product
- 15.5.3. By End User
- 15.5.4. By Application
- 15.5.5. By Technique

16. Europe Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
- 16.4.1. By Country
  - 16.4.1.1. Germany
  - 16.4.1.2. Italy
  - 16.4.1.3. France
  - 16.4.1.4. U.K.
  - 16.4.1.5. Spain
  - 16.4.1.6. Rest of Europe
- 16.4.2. By Product
- 16.4.3. By End User
- 16.4.4. By Application
- 16.4.5. By Technique
16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Product
- 16.5.3. By End User
- 16.5.4. By Application
- 16.5.5. By Technique

17. South Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
- 17.4.1. By Country
  - 17.4.1.1. India
  - 17.4.1.2. Thailand
  - 17.4.1.3. Indonesia
  - 17.4.1.4. Malaysia
  - 17.4.1.5. Rest of South Asia
- 17.4.2. By Product
- 17.4.3. By End User
- 17.4.4. By Application
- 17.4.5. By Technique
17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Product
- 17.5.3. By End User
- 17.5.4. By Application
- 17.5.5. By Technique

18. East Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
- 18.4.1. By Country
  - 18.4.1.1. China
  - 18.4.1.2. Japan
  - 18.4.1.3. South Korea
- 18.4.2. By Product
- 18.4.3. By End User
- 18.4.4. By Application
- 18.4.5. By Technique
18.5. Market Attractiveness Analysis
- 18.5.1. By Country
- 18.5.2. By Product
- 18.5.3. By End User
- 18.5.4. By Application
- 18.5.5. By Technique

19. Oceania Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
- 19.4.1. By Country
  - 19.4.1.1. Australia
  - 19.4.1.2. New Zealand
- 19.4.2. By Product
- 19.4.3. By End User
- 19.4.4. By Application
- 19.4.5. By Technique
19.5. Market Attractiveness Analysis
- 19.5.1. By Country
- 19.5.2. By Product
- 19.5.3. By End User
- 19.5.4. By Application
- 19.5.5. By Technique

20. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
- 20.4.1. By Country
  - 20.4.1.1. GCC Countries
  - 20.4.1.2. Northern Africa
  - 20.4.1.3. South Africa
  - 20.4.1.4. Rest of Middle East and Africa
- 20.4.2. By Product
- 20.4.3. By End User
- 20.4.4. By Application
- 20.4.5. By Technique
20.5. Market Attractiveness Analysis
- 20.5.1. By Country
- 20.5.2. By Product
- 20.5.3. By End User
- 20.5.4. By Application
- 20.5.5. By Technique

21. Key Countries' Molecular Diagnostics in Infectious Disease Testing Market Analysis 2022-2032

21.1. Introduction
- 21.1.1. Market Value Proportion Analysis, By Key Countries
- 21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.2.1. By Product
- 21.2.2. By End User
- 21.2.3. By Application
- 21.2.4. By Technique
21.3. Canada Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.3.1. By Product
- 21.3.2. By End User
- 21.3.3. By Application
- 21.3.4. By Technique
21.4. Mexico Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.4.1. By Product
- 21.4.2. By End User
- 21.4.3. By Application
- 21.4.4. By Technique
21.5. Brazil Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.5.1. By Product
- 21.5.2. By End User
- 21.5.3. By Application
- 21.5.4. By Technique
21.6. Germany Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.6.1. By Product
- 21.6.2. By End User
- 21.6.3. By Application
- 21.6.4. By Technique
21.7. Italy Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.7.1. By Product
- 21.7.2. By End User
- 21.7.3. By Application
- 21.7.4. By Technique
21.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.8.1. By Product
- 21.8.2. By End User
- 21.8.3. By Application
- 21.8.4. By Technique
21.9. China Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.9.1. By Product
- 21.9.2. By End User
- 21.9.3. By Application
- 21.9.4. By Technique
21.10. Japan Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.10.1. By Product
- 21.10.2. By End User
- 21.10.3. By Application
- 21.10.4. By Technique
21.11. S. Korea Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.11.1. By Product
- 21.11.2. By End User
- 21.11.3. By Application
- 21.11.4. By Technique
21.12. India Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.12.1. By Product
- 21.12.2. By End User
- 21.12.3. By Application
- 21.12.4. By Technique
21.13. Australia and New Zealand Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.13.1. By Product
- 21.13.2. By End User
- 21.13.3. By Application
- 21.13.4. By Technique
21.14. South Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis
- 21.14.1. By Product
- 21.14.2. By End User
- 21.14.3. By Application
- 21.14.4. By Technique

22. Market Structure Analysis

22.1. Market Analysis by Tier of Companies (Molecular Diagnostics in Infectious Disease Testing)
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
- 22.4.1. By Regional footprint of Players
- 22.4.2. Product foot print by Players
- 22.4.3. Channel Foot Print by Players

23. Competition Analysis

23.1. Competition Dashboard
23.2. Pricing Analysis by Competition
23.3. Competition Benchmarking
23.4. Competition Deep Dive
- 23.4.1. Abbott Laboratories
  - 23.4.1.1. Overview
  - 23.4.1.2. Product Portfolio
  - 23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.1.4. Sales Footprint
  - 23.4.1.5. Strategy Overview
    - 23.4.1.5.1. Marketing Strategy
    - 23.4.1.5.2. Product Strategy
    - 23.4.1.5.3. Channel Strategy
- 23.4.2. Becton
  - 23.4.2.1. Overview
  - 23.4.2.2. Product Portfolio
  - 23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.2.4. Sales Footprint
  - 23.4.2.5. Strategy Overview
    - 23.4.2.5.1. Marketing Strategy
    - 23.4.2.5.2. Product Strategy
    - 23.4.2.5.3. Channel Strategy
- 23.4.3. Dickinson and Company
  - 23.4.3.1. Overview
  - 23.4.3.2. Product Portfolio
  - 23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.3.4. Sales Footprint
  - 23.4.3.5. Strategy Overview
    - 23.4.3.5.1. Marketing Strategy
    - 23.4.3.5.2. Product Strategy
    - 23.4.3.5.3. Channel Strategy
- 23.4.4. bioMerieux
  - 23.4.4.1. Overview
  - 23.4.4.2. Product Portfolio
  - 23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.4.4. Sales Footprint
  - 23.4.4.5. Strategy Overview
    - 23.4.4.5.1. Marketing Strategy
    - 23.4.4.5.2. Product Strategy
    - 23.4.4.5.3. Channel Strategy
- 23.4.5. Thermo Fisher Scientific Inc.
  - 23.4.5.1. Overview
  - 23.4.5.2. Product Portfolio
  - 23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.5.4. Sales Footprint
  - 23.4.5.5. Strategy Overview
    - 23.4.5.5.1. Marketing Strategy
    - 23.4.5.5.2. Product Strategy
    - 23.4.5.5.3. Channel Strategy
- 23.4.6. F. Hoffmann-La Roche Ltd
  - 23.4.6.1. Overview
  - 23.4.6.2. Product Portfolio
  - 23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.6.4. Sales Footprint
  - 23.4.6.5. Strategy Overview
    - 23.4.6.5.1. Marketing Strategy
    - 23.4.6.5.2. Product Strategy
    - 23.4.6.5.3. Channel Strategy
- 23.4.7. Siemens AG
  - 23.4.7.1. Overview
  - 23.4.7.2. Product Portfolio
  - 23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.7.4. Sales Footprint
  - 23.4.7.5. Strategy Overview
    - 23.4.7.5.1. Marketing Strategy
    - 23.4.7.5.2. Product Strategy
    - 23.4.7.5.3. Channel Strategy
- 23.4.8. Veridex, LLC
  - 23.4.8.1. Overview
  - 23.4.8.2. Product Portfolio
  - 23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.8.4. Sales Footprint
  - 23.4.8.5. Strategy Overview
    - 23.4.8.5.1. Marketing Strategy
    - 23.4.8.5.2. Product Strategy
    - 23.4.8.5.3. Channel Strategy
- 23.4.9. Luminex Corp.
  - 23.4.9.1. Overview
  - 23.4.9.2. Product Portfolio
  - 23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.9.4. Sales Footprint
  - 23.4.9.5. Strategy Overview
    - 23.4.9.5.1. Marketing Strategy
    - 23.4.9.5.2. Product Strategy
    - 23.4.9.5.3. Channel Strategy
- 23.4.10. GenMark Diagnostics, Inc.
  - 23.4.10.1. Overview
  - 23.4.10.2. Product Portfolio
  - 23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.10.4. Sales Footprint
  - 23.4.10.5. Strategy Overview
    - 23.4.10.5.1. Marketing Strategy
    - 23.4.10.5.2. Product Strategy
    - 23.4.10.5.3. Channel Strategy
- 23.4.11. Qiagen N.V.
  - 23.4.11.1. Overview
  - 23.4.11.2. Product Portfolio
  - 23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.11.4. Sales Footprint
  - 23.4.11.5. Strategy Overview
    - 23.4.11.5.1. Marketing Strategy
    - 23.4.11.5.2. Product Strategy
    - 23.4.11.5.3. Channel Strategy
- 23.4.12. Genomix Biotech
  - 23.4.12.1. Overview
  - 23.4.12.2. Product Portfolio
  - 23.4.12.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.12.4. Sales Footprint
  - 23.4.12.5. Strategy Overview
    - 23.4.12.5.1. Marketing Strategy
    - 23.4.12.5.2. Product Strategy
    - 23.4.12.5.3. Channel Strategy
- 23.4.13. bioTheranostics
  - 23.4.13.1. Overview
  - 23.4.13.2. Product Portfolio
  - 23.4.13.3. Profitability by Market Segments (Product/Channel/Region)
  - 23.4.13.4. Sales Footprint
  - 23.4.13.5. Strategy Overview
    - 23.4.13.5.1. Marketing Strategy
    - 23.4.13.5.2. Product Strategy
    - 23.4.13.5.3. Channel Strategy

感染症検査向け分子診断の世界市場：北米が引き続き世界市場の成長を牽引

Market Study on Molecular Diagnostics in Infectious Disease Testing: North America to Continue Leading Global Market Growth

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

第4章 規則と規制

第5章 世界の感染症検査向け分子診断市場の需要分析と予測

第6章 世界の感染症検査向け分子診断市場：価格分析

第7章 世界の感染症検査向け分子診断市場の需要分析と予測

第8章 市場の背景

第9章 世界の感染症検査向け分子診断市場分析と予測：製品別

第10章 世界の感染症検査向け分子診断市場分析と予測：用途別

第11章 世界の感染症検査向け分子診断市場分析と予測：技術別

第12章 世界の感染症検査向け分子診断市場分析と予測：エンドユーザー別

第13章 世界の感染症検査向け分子診断市場分析と予測：地域別

第14章 北米の感染症検査向け分子診断市場分析と予測

第15章 ラテンアメリカの感染症検査向け分子診断市場分析と予測

第16章 欧州の感染症検査向け分子診断市場分析と予測

第17章 南アジアの感染症検査向け分子診断市場分析と予測

第18章 東アジアの感染症検査向け分子診断市場分析と予測

第19章 オセアニアの感染症検査向け分子診断市場分析と予測

第20章 中東・アフリカの感染症検査向け分子診断市場分析と予測

第21章 主要国の感染症検査向け分子診断市場分析

第22章 市場構造分析

第23章 競合分析

第24章 前提条件と使用されている頭字語

第25章 調査手法